🔗 Visit the ClinicalTrials.gov page for NCT00015704
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial. | JAMA | 2000 | 2.20 |
| 2 | Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk. | PLoS One | 2008 | 1.20 |
| 3 | Interleukin-2-associated viral breakthroughs induce HIV-1-specific CD4 T cell responses in patients on fully suppressive highly active antiretroviral therapy. | AIDS | 2003 | 0.82 |
| 4 | Interleukin-2--where are we going? | J Assoc Nurses AIDS Care | 2003 | 0.77 |
| 5 | Immune restoration in patients with HIV infection: HAART and beyond. | J Assoc Nurses AIDS Care | 2003 | 0.77 |
| 6 | Methods of using interleukin 2 to enhance HIV-specific immune responses. | AIDS Res Hum Retroviruses | 2002 | 0.75 |